Here are three more report takeaways:
- Total deal volume through the first half of the year declined more than 20 percent compared to the first half of 2021.
- Despite fewer deals, the first half of 2022 could outperform the first half of 2021 because most capital in 2021 was invested in the second half of the year.
- With the size and capital of the current market, the report predicts the main way for investors to generate return will be through on-the-ground valuation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.